Chemoinformaics analysis of alpha-Duprezianene
Molecular Weight | 204.357 | nRot | 0 |
Heavy Atom Molecular Weight | 180.165 | nRig | 13 |
Exact Molecular Weight | 204.188 | nRing | 4 |
Solubility: LogS | -5.111 | nHRing | 0 |
Solubility: LogP | 4.916 | No. of Aliphatic Rings | 4 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 2 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 41.053 |
nHD | 0 | BPOL | 24.077 |
QED | 0.513 |
Synth | 5.519 |
Natural Product Likeliness | 2.767 |
NR-PPAR-gamma | 0.009 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.405 |
Pgp-sub | 0 |
HIA | 0.004 |
CACO-2 | -4.636 |
MDCK | 0.0000155 |
BBB | 0.11 |
PPB | 0.953757 |
VDSS | 1.219 |
FU | 0.0369373 |
CYP1A2-inh | 0.335 |
CYP1A2-sub | 0.515 |
CYP2c19-inh | 0.449 |
CYP2c19-sub | 0.894 |
CYP2c9-inh | 0.532 |
CYP2c9-sub | 0.634 |
CYP2d6-inh | 0.17 |
CYP2d6-sub | 0.821 |
CYP3a4-inh | 0.36 |
CYP3a4-sub | 0.35 |
CL | 5.631 |
T12 | 0.151 |
hERG | 0.008 |
Ames | 0.002 |
ROA | 0.079 |
SkinSen | 0.392 |
Carcinogencity | 0.022 |
EI | 0.979 |
Respiratory | 0.844 |
NR-Aromatase | 0.18 |
Antiviral | Yes |
Prediction | 0.930264 |